RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 11 analysts with an average price target of $254.45. This is a potential upside of $17.87 (15.69%) from yesterday's end of day stock price of $219.95.

ResMed's activity chart (see below) currently has 219 price targets and 232 ratings on display. The stock rating distribution of RMD is 69.7% BUY and 30.3% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75.58% with an average time for these price targets to be met of 191.22 days.

Highest price target for RMD is $321, Lowest price target is $215, average price target is $254.45.

Most recent stock forecast was given by BRETT FISHBIN from KEYBANK on 31-Aug-2026. First documented stock forecast 27-Jun-2013.

Currently out of the existing stock ratings of RMD, 23 are a BUY (69.7%), 10 are a HOLD (30.3%).

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Buy Since 06-Feb-2024

$267

$38.65 (16.93%)

$255

10 days ago
(31-Aug-2026)

7/13 (53.85%)

$26.9 (11.20%)

142

Hold Since 13-Oct-2025

$215

$-13.35 (-5.85%)

$225

1 months 3 days ago
(07-Aug-2026)

4/5 (80%)

$3.06 (1.44%)

39

Hold Since 07-Aug-2026

$244

$15.65 (6.85%)

$234

1 months 3 days ago
(07-Aug-2026)

24/30 (80%)

$32.06 (15.13%)

292

Hold Since 10-Jan-2025

$225

$-3.35 (-1.47%)

$275

1 months 3 days ago
(07-Aug-2026)

5/5 (100%)

$13.06 (6.16%)

46

Buy Since 14-Apr-2023

$220

$-8.35 (-3.66%)

$300

1 months 26 days ago
(15-Jul-2026)

16/17 (94.12%)

$21.43 (10.79%)

107

Show more analysts

Please expand the browser size to see the chart

What is RMD (ResMed) average time for price targets to be met?

On average it took 191 days for the stock forecasts to be reached, with an average price target met ratio of 75.58%.

Which analyst most recently updated their price target on RMD (ResMed)?

Brett Fishbin

Which analyst has the most public recommendations on RMD (ResMed)?

Brett Fishbin works at KEYBANK and has 7 price targets and 4 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

Craig Wong-Pan with the highest potential upside of $120.71

Which analyst is the currently most reserved on RMD (ResMed)?

Andrew Paine with the lowest potential downside of -$204.74

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?